Kyverna Therapeutics has reported new data with its cell therapy for the rare autoimmune disease stiff person syndrome (SPS), miv-cel, that reinforces its safety as it prepares to complete a rolling ...

The FDA's experts looked at data from NHS-Galleri, as well as the US and Canadian PATHFINDER 2 study, which enrolled more than 35,000 subjects and showed that the test was able to increase cancer ...

The FDA has approved Eli Lilly's once-weekly basal insulin product Onswik for adults with type 2 diabetes, setting up a market tussle with Novo over its recently launched Awiqli. Onswik (insulin ...

Eli Lilly has continued a busy period of deal-making with a wide-ranging partnership with China's InnoCare Pharma that includes upfront and near-term payments of $100 million. There's another $3.25 ...

That's where The PM Society comes in. As the professional organisation for people working in pharmaceutical marketing and healthcare communications, The PM Society brings together peers from across ...

The infiltration took place in June, but OpenAI has indicated it only became aware of the incident in August and notified the Australian government – by email to a general inbox – in September. It is ...

T-cell therapy has been transformational in treating liquid tumours, historically, translation to application in solid tumours has faced biological barriers. Nonetheless, in June 2026, China approved ...

One area where AI is both essential to implement and important to get right is pharmacovigilance, the group concerned with monitoring and maintaining patient safety. In today's pharmaphorum podcast, ...

The next era of health innovation will not be shaped by scientific progress alone. It will depend on how regulation evolves, how effectively data is used, whether innovation reaches patients, and how ...

The Swiss pharma group has just reported topline results from the phase 3 IMAgINATION study of Factor B inhibitor sefaxersen ...

AI-powered drug discovery companies Enveda Biosciences and Basecamp Research have completed impressive funding rounds – worth ...

Orca Bio's manufacturing facility in Sacramento, California. Orca Bio has become a commercial-stage company with the FDA approval of Tregzi, a cell-based immunotherapy designed to prevent graft-versus ...